Repurposing existing medications to reduce severe acute respiratory distress in patients with COVID-19: the CLARITY trial
- Funded by Medical Research Future Fund (MRFF)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$2,550,986.18Funder
Medical Research Future Fund (MRFF)Principal Investigator
N/A
Research Location
AustraliaLead Research Institution
UNSW SydneyResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Prophylactic use of treatments
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
MRFF Respiratory Medicine Clinical Trials Research on COVID-19 Grant Opportunity research recipient